OA15.04 Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC

Solange Peters, B.C. Cho, A. Luft, Jorge Alatorre-Alexander, S.L. Geater, S.-W. Kim, G. Ursol, M. Hussein, F.L. Lim, C.-T. Yang, L.H. Araujo, H. Saito, N. Reinmuth, R. Stewart, Z. Lai, R. Doake, Lee M. Krug, E.B. Garon, T. Mok, M.L. Johnson